PhRMA’s Post

#Medical_Research, as a dynamic field, encompasses a wide spectrum of investigations, ranging from the microscopic intricacies of cellular function to the macroscopic challenges of public health. Here, we are going to continue the previous note by providing a short brief of two other fields of 10 top medical research trends in 2024: 1- Novel Drug Development 2- Medical Regulatory Technology #Novel_Drug_Development stands at the forefront of scientific innovation, representing a multifaceted and dynamic process that transforms promising compounds into therapeutic agents. The overarching goal is to #discover and bring to market #new_medications that address unmet medical needs, improve patient outcomes, and advance the landscape of #healthcare. #Medical_Regulatory_Technology, often referred to as MedTech, represents a rapidly evolving field at the intersection of healthcare, technology, and #regulatory_compliance. It encompasses a diverse range of technological solutions designed to streamline and enhance various aspects of healthcare regulation, ensuring that medical products and services meet stringent standards for safety, efficacy, and quality. (StartUs Insights)

Looking to reduce the cost of clinical trials? Check out this informative article that highlights 3 ways biotechs can lower their expenses. #ClinicalTrials #BiotechIndustry

You hear the term "digital twin" a lot these days, so we wrote a white paper talking about its origins and various uses within medicine. Give it a read! #digitaltwins #unlearn #ai #artificialintelligence #ml #medicine

Our new whitepaper, “Defining digital twins in drug discovery and development,” dissects the journey of the term digital twins from its engineering origins to its current healthcare applications, highlighting how the complexity of biological systems challenges its definition and necessitates a nuanced understanding of its capabilities and limitations. https://bit.ly/43zwE0T #DigitalTwins #Healthcare #ClinicalResearch

Good news! Our latest research shows that 89% of healthcare professionals have noticed improvements in the digital supply of scientific information in the last 2 years.   But, while most in #pharma consider the overall effectiveness of their #HCPengagement activities to be at least ‘satisfactory’, demonstrating impact on clinical behaviour remains a stubborn challenge.   Discover valuable research insights to steer your strategy in this article: https://lnkd.in/esJ6KXqn

More equitable and fair distribution of biomedical innovation is a shared responsibility. Our report maps out relevant initiatives on public return and provides recommendations to a range of stakeholders. Read the report here: https://lnkd.in/eECdY-uv

Market approval does not guarantee commercial or clinical success. Regulatory considerations, #patientadherence and inflexible clinical workflows can hinder product uptake. Our cutting-edge #implementationscience services can help you address these barriers and optimize product adoption. Learn more. » https://bit.ly/471FmGG

The landscape of clinical trials is undergoing a profound transformation, promising faster drug development, increased patient participation, and improved data quality. Watch how technology is transforming the way we conduct clinical research: https://lnkd.in/eFdH9hf2

From revolutionising drug development to enhancing medical diagnosis and treatment, these technologies are reshaping the healthcare landscape.

From revolutionising drug development to enhancing medical diagnosis and treatment, these technologies are reshaping the healthcare landscape.